In Brief This Week: Mainz Biomed, Centogene, DermTech, Freenome, Theradiag, More
News items for the week of April 10, 2023.
In Brief This Week: SQI Diagnostics, Chembio, Accelerate, Seegene, Freenome, More
News items for the week of March 27, 2023.
Freenome Partners With Geisinger to Recruit Patients for Multi-Cancer Screening Study
The Pennsylvania health system will be able to access patients in both urban and rural settings, aiding Freenome's goal to recruit a total of 8,000 individuals.
Freenome Launches Multi-Cancer Detection Study Using Multiomics, Real-World Evidence
The company plans to analyze both traditional and real-world data from about 8,000 individuals to validate and optimize its multi-cancer early detection platform.
Freenome Nets $290M Investment From Roche
The company said the latest influx brings its total funding to more than $1 billion and will help the firm expand its cancer detection platform to multiple tumor types.
Dec 7, 2021
Freenome Raises $300M in Series D Financing
Apr 1, 2019